Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10004-10016
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10004
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10004
Table 6 Protective effect of astragaloside IV on kidney disease
Disease categories | Study object/model | Effect induced by autophagy | Mechanism (targets or pathways) | Ref. |
Chronic glomerular nephritis | Cationic bovine serum in rats | (+) Kidney function, (-) kidney lesion, (-) inflammatory, (+) autophagy | (-) The activation of PI3K/AKT/AS160 pathway | Lu et al[46] |
Diabetic kidney disease | A high-fat diet in the diabetic KK-Ay mice | (+) Renal function and morphology by (+) autophagy | (-) MC activation through the SIRT1-NF-κB pathway | Wang et al[47] |
- Citation: Yang Y, Hong M, Lian WW, Chen Z. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation. World J Clin Cases 2022; 10(28): 10004-10016
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10004.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10004